{"ticker": {"uuid": "54f77f18-42ab-4588-a5ec-33532e290d8d", "symbol": "GLENMARK", "name": "Glenmark Pharmaceuticals Limited", "exchange": "NSI", "country": "IN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Glenmark Stock - analyst consensus and valuation snapshot", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNQTA2MkZqakJNS1QtU2F2SExRN2hZUDR4U0NFVEl5c25CMGVfZjZUSGpCd0dLYTRKWnl4R2x5OVNuNHVSUGdxX3dMbVN3Ym52eVl6VnF6X2xUdVRwamFwQ2xmeXhZWDgyVWdkRkpRRGdLMnA5LWlOU0JpanVTYzJOU1VVdHFaczkzRXBfdS03U0VOdWdNWDdMLWxDZi1WSVZiYm9PT0RzN245NXNVSE5PR21DVWc?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-21T20:38:15+00:00", "published_display": "21 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Stock - analyst consensus and outlook midyear", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPejRFWi10d01fVDR5N3hyUFBrQ002Rlh5N1VvY0dFekc5U3EyUW1HSzlOdzJXcjY5WWExUnZRZzBYcUtNNTY2NjZaMmE3OHRLRVJyMHhzOEFLeHBzN084bGRQcDQ1czVFTUJiRS1FR0VNYUlRZ29yY28zZkthQXVtS0hPZ1VOWnU5NU5salVmMmFIU3lER0pGczlRZFJ1VFFUNndfVHhNNzRvQXdxblZGcg?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-17T19:49:10+00:00", "published_display": "17 Jun 2026 19:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark launches Methylene Blue Injection in US market", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPcGJBQ0o4WHR3ZmhKTkZVZ2pKMTIxZjR3VGZya3I4b29PeEJWZWhmZ1pINzVWbWI0a0E1N0hBRm5IVl93T05rZEQyVHoxNVNLWEdfMWJFTndBNmtRZWVfdERibExZUXNQTUJOeE16VHJwYmpKQWZ4RmVsX2ZiQlpSS3BSampyWDhaajhpbGFCNmJSbmJaSGlxdHFsSWFMUWtqXzlCdzZEWEtNZHhEWVhLc2FR?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-17T04:17:23+00:00", "published_display": "17 Jun 2026 04:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharmaceuticals launches Winlevi across key European markets", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma Profit Expected To Soar 5x in Two Years, Says Motilal Oswal \u2014 Check Target Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOY09WdW11YzhKNjlPZ09LWndBb1FYS1dyNEJESTE4YmNQN3NnWUNoVWlXTUNuRUhjN19KdnhPclVNdGN5ejFRc1FCQVdxcTFQbkJlRDl4Qy16bnh4TjhVdHJpUmdKSWppRWdIYkRtNDBYNUxpeXY2ek9KWnAxTS1KVVVLSEFyRHJpazBXRk5SSE5oN2tUdnNFVlpoUXEtdkdwUHVCSmNTcGVZYzNkQVYtMkYzRjI2dDV0ZUNweHBOZzZYRjJNUkhXSGNLQkMtUlVqTHVF?oc=5", "source_name": "NDTV Profit", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Glenmark Pharmaceuticals' (NSE:GLENMARK) Healthy Earnings Might Be Conservative", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPd3NlQ0hiWkpJbE9saUxpR05ic1o5TDEtaS1XaW40WlpjWGQyRkNvSVNLWUNwMzBYakV5Y0hpM2t6QVJwSE1mQVZXalJvR3BLX3JVZlV0ZzUtLUNtZjRaVi15REdTcm5CSGlHbmV0dmlYbVJ5Q1owSFdnV3ViN19xbXNoOHIxRHFDdmhhX0ZFUzN1YkkzRG13VzZVM2dhN2g3TTJNMlMzWjVnMm02MWRfclhnZERmVzA1eXNYMEtDZjVWOFEtT2VLNkI3RVJkMkdnX09zUlc0czJTM0JZMVJaaUFBQzJEMjVMLWVOT3NJclJobGx2ell5aGNB0gH_AUFVX3lxTE9CQ09PNWIyTjFjNEJEd3ZZSjkyeERENEJRNHJ5MzZBUmx4V1VXMmF5cVI0ZG1EWDZNR0laRDM5S1RVbl9pZXE0RFF2aVN3M2E0dTk5OHNkQW10Vi1icjdtX0FIVXhuN0JnNnV6dHZfNnhOc0FKUTNQSkFROTh6aVJ5Um1NaFBQUVQtcnVKUUZNOWFtQkoxSzlKM2dJX3l0TWFHZFI1SUJJTTNXcDdnLW1mbnRVUEtMbUZGbzBzSGFZUzNHR2huTXJWa21vOG1RRUliMHlIczNzZWZ2ZGtjcDRmWWdESTZZVU5mcURheWF2TEhwRjV2WHFNOS1rM3pUOA?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Launches Lacosamide Injection; Shares Rise 1%", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNVUJ1cUVwTkMzUU5lM0RSdXVvWXBWTGRWWGVGaTY2dm9PejRvRERUbk9CbjRqRnlBWTlxS051ZzNhSGppdDdiR2ZFUlhkYUEzWkU3OGp3aUpyT3E1UkNMT2RMX2x1WV9QRTZuc0JBX1pSTDdXSV82UXJoM2ctTndHNFFFQUplM2JSYlNidW9keFBFRDFZOUx3?oc=5", "source_name": "HDFC Sky", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Now The Time To Put Glenmark Pharmaceuticals (NSE:GLENMARK) On Your Watchlist?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxOcE1lTkVPOHZhWFN4QTdIQlFOT2VlTEg5SGJmVFl1eklfTHpGSzBwQlMxSlMzcURwYUZ4bGVtZGpTc29xSmJSelFaRU53WGZwN29KWlhfR3JCWHBhbXh4cGFKbTFhNThNSFdJeFZaYWs2U0FaOW5hZ29WQ2hyQV9qT2tja19icEE4RW9JbUxXd3ZpVXpYcjVFbXlQbFhWOTA3OTU0YXBrWU1Yal9RMzJ5cVdXTExfcTgyZkY0aUZ5NDZZWjU5UlV1NEF1Vm0zT1ZoTTJKd0M5bGdQOTZldmdoTS1nb01UTXRpdmtxaVo1QVBtZW5PQkNLS3lKMNIBgAJBVV95cUxQTmFLbjhBODhUYUhZd0l4OFFxNVVWU3d4dHppVVNCWllpMWZFZlpoQ0xmVldaT1dVRVBlU1lXMFBoRTJ6aUtKenpFbGZJUlphNm5OU3FUN1FMU0FDU08ybnRwUGdmeWRJd0g3ODR3UHUtYmxrN25id2JQZzZkZ1NkdmFFNmgybi1tOHFrcHpzSXQtc0gyRkc0Q0JzLXdiaHhoTDhlVDhMUG5hNXF3ZlFOald2N2lxVEtlLUJkblNQWldSUnAtaldzVHoyY2lmSzFDYnA0OVBzc18zOUtraWFwX2loa0JINUlCMUdMZ2otY2ZFeXF5UkRCUUtBSHc3WFJO?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks to Watch for June 1: IndiGo, Glenmark Pharma, Lupin, NMDC, textile stocks and more", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma Q4 Result: Net Profit Soars 64 Times, Revenue Rises; Dividend Declared", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNSmdjbE1ySHpCWHZlQk9KQ205ZDFORGlKN0FEd2V0aTVRZFZCU3hiYi0wTTQwbUIxNFVla3QwVm1Vb0FrZWo2WjVwZnpzeTF1cE40eUlOemJfZkFJc2o2ejhDWVFqd09USHNMLXlUTE9UMWl0M0QxSlptX0JyYmNWYV9OeWthVmtpUGVKYV83UGR3ZXhuNlJuT2tfeHhSTVpNVFN6ZE9UeXUtQ09jaFpSdUNyeVpYaDJEZGZXelFyR2x6S0JVZUHSAc4BQVVfeXFMUFEzWWVRd0QwbGR4NGwwRDNyaU5POVlEa3l0MzV3Q0pJX3RSY1IzcHc5Q0xhS1pVVHlBUnZrQ0hrd1Y3dldwRzRnMU5ERHdQT05zUWtlREp3MU8wWXJ3SmVjeERUdEFCMEQxQmFHYTlPM0d3U1ZLa3hCTHVPRmgyeXk2YU55TVJfS0FLSFJHZW1zS3kzWlFDcDBCQzI1QkJCNTNWT2tTbElpU1FFcG5Rd2hVbUNnS2pVdXBRVXRPSkE1bEZRQ1RYelhvcGQ4eXc?oc=5", "source_name": "NDTV Profit", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma Q4 net profit zooms to \u20b9301 crore; recommends 250% dividend", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark to host Annual Investor Day 2026 on June 9", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQSjcyNlBtc2d5UmMzWHFjM3ZheHdJa1oxclhPQ29hd29rdmZiZTJINFVKcU1OZlAxVkVNRmUzU1Q3U3JTNGtxR0piaGZoQXhaLURmNmxMZ1dOZkY1QkJHLWxXT2N6V2NyYVhzeGxLblZ0ZGtUVjA0S3FQR1BxVDc3N2R2QnB5UUJXWHBRRDBEX01ISUdkTGZuYml0VGZwRzZCSEVWMTZna2JOYURy?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharmaceuticals stock (INE935A01035): shares under pressure on NSE India as investors track", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOamdUS05XTzlFcWUzQmVlWDZWMWwwODJLR1F1UnhyTEJjWWRvY0FfeWRXdnl1Yi1fRTlFTkxhcHVLbTNNcXdZbC1QLWtLZEowM3lLdmxtS0hRMkt3d2NsOXNjcGpnZ2s3RnRYNHdlMnNiTXRIaThZYWhadEpsRzA1alZLMjNURXBWTERfU0N0dFk5RHpSTDRyUmVaOHpYblNRTi1KRXMtVFA2cnUwVmFvbW9XMkhEc29CaHRNMXBpOFVGMFRNamc?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks to Watch Today: TVS Motor, Exide Industries, Meesho, Groww, Gujarat Themis, Glenmark Pharma,...", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Launches Vancomycin Injection; Shares Dip 0.36%", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPMk1abzhNRFIwNXg1Q1FFb296a2Jmbm5vSGsxWVBlVTZIelM0YkVBZW5xY1RpVU5ELXgxTmlqd1lZTi0yN3pkUWw3ZFhWSU1zYTlLS1F6SG04NlAxUFJtODF3bzl1VEJPS0VSaTlHMjBTRndKVnVOR0tEQjlJelhULTJwQ2VLZmM0VXFDTVJmZ1F1V0pUdkFYeVdR?oc=5", "source_name": "HDFC Sky", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharmaceuticals Ltd slips for fifth straight session", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxPdmE1QW43MVdsclhUT0tOMU12N0lZMnNJRjlXM2FXNjdYZFEtM0kwNHlsaEVKSnZxMmZVYnk4U1BHSGpRM2NMbnBLdGtUX0I1Z09mVnR6aWpKVjZZRVFCRmhkbHlyOGxHM3FfSzI3QTJ0NjdCaUtlTzhfZDVTdUxTNFA5ZTk5elJHWUR0QW5hcHZ1cXpWN3hhRklCbklKUFZ3cFY1cFlOWDFZYTFWN2w1eTA0b2xkMVhDOU1fdUc5UmRlTVNiZmVvc3c2WG1DMDhRcVBhWnhnaFREZGvSAeABQVVfeXFMTXh4SDlQSDQ4Vmx5OHhWRkpjWkhNWWNzN3BwLUpoVWJ0TWVuTzVJakNOWlZmVmVFZUE3SWFkb1BIQ0o2d1hOSTU4QWpubjEtcUFyZlA5enR5aHRUaFJBd0JNWnczWXp3Z3kyZHNLQnN5OTNYSlpvZ28wQmwwNGxNM3FNUlZZaXpHV1MwT1JNbkpjRXJLU1BmNXB6UGFOb3JxbWhDMmVWeVJ5T2xCN2lxRnNhcVhlbzg3TFIwNEEtdmlJcTVuNDQzYW9nWFlleld0Vk1BRmRxbTVoNG1rWFVBUm0?oc=5", "source_name": "Business Standard", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nifty eyes 24,600; SBI, Glenmark Pharma, Tata Power on analyst radar", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma may outperform amid market correction; technicals turn positive: Ruchit Jain", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trade Spotlight: How should you trade Avenue Supermarts, Glenmark, Bharat Dynamics, Torrent Pharma,...", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma Q3: Profit, revenue up over 15% as India, North America drive growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Q3 profit rises 16% on strong India, US performance", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Q3 profit rises 15% on strong market performance; Revenue up 15%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma stock gains 3% on launch novel COPD treatment; details here", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2025-11-25T08:00:00+00:00", "published_display": "25 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharmaceuticals Limited Just Beat Revenue By 16%: Here's What Analysts Think Will Happen Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPamVkem9vaTRQemUyNmIxOVEySHVLVEZmazhLMWVkRFdCbjF0VllOd0ZNcEVGTmQ0YzBZNHR5c0drTktmbVFjYlY2RnQySEZlcU1OVEJHTGtZdG5HME1rWHdzTlo2alRPQTRVekE5TUZHWGhsYlRxejUwZV9vd0lBTFVDVTN2LWVieFBmaWF1NmhGYmVDSHgxMTFJYndpU3FXelRHUDdwbnNWd1BIVjFaQnd0NWhHTTNCWTZBeTlfZ3JGak9iWkl0ejVUUjdEWWVTbHhDOXdpVWdZRElmXzVzRVd4TkViRTFHMC1fQm5jVXh0TEM1SmxSVWZB0gH_AUFVX3lxTFA3cG1pSVVOU3gzNnlkRTdTRHdCaG1nM2tGaDV2MVhRaVg1WkNjZml1ZGV4aFc5THdBQ1daU2pvdm9ZMjhPbFhzalg4UGtHT244NWJuS0NQX1lIbEx6ajlhU1hqemtaeldkUXBVLUxrOXhHRjlMMnFNWGdJblRUY1B3U2ZxS0ZVRWljNENqMm14bUlBWjBKUmJyY1E3clllUFpiRlZ6dkdGQmliUGhXclR0a08xMVV3NFk1ZlZKMHVZb0lKTW5HNmtrWmJCQlRkRTZsOTg5OHJIaktZcGRZa1FEMUVZNjlISXdkYVVoNHFzNmtmZklubkxRV3laTjJHSQ?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-19T08:00:00+00:00", "published_display": "19 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Getting In Cheap On Glenmark Pharmaceuticals Limited (NSE:GLENMARK) Might Be Difficult", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPQjVHbEFwa19pYmJhaHhlLVpjUmRUczFrWkNqdnlXX01ucEx2LUp3TUIzcGRpQWpuV1dabjhKV0V3Wl83ZHc0V0p0el9IdDUtTmtfUExDRWFmTFJYbm9QWlowakxpWnhuamVxbThWUVl0andMU0pzV0xHVWs4dUxaSV9JdkczX2kySHJPcXI2V08xQXFvOWRWU2h3VHBKeXBFbjNwRlBsRWQxOS1ncjVPcDdYTlNiUkhLdklWZDFyYlpSZlB4ZlpjUlptaG84azFjTHdHd1JpSjdqejdWWVR4ZkxXV21lTUdYX1pCeko0WHYzczQ2ZmZsTzZn0gH_AUFVX3lxTE45UU1RQjVGVmF1N0gxbllURDNyWlNLR2pUb2RySGFSMjEwaHBOdGswcmFQd0dXSTdMSVR5Q2xackVzVzNNMnZPZ0RKYTlla3JneHlQc3Y0aDZRYVNkVVhSUEEyS25IQ0sxYkdSdzZGOHA4Wjl1aldTU0xpa1dhVk5UTVkwdXFoREJkSEdUYWRmWnByU0Q5SlJQcFpQMnVrTHB0ZnRUeURSUlpmRTFhcVlFWEEyeG15MU5FQWlfbk4tckFiREF1Tm94NGVGQzF6Z1dSUGFXM1daQVI3eDlkelNXS3pZNjlLbVY1RVZlOGd2bVY3bmVjOXpDZFRLaTdZVQ?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-12T08:00:00+00:00", "published_display": "12 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why Glenmark Pharmaceuticals Limited's (NSE:GLENMARK) CEO Compensation Is The Least Of Shareholders' Concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxNQjFKQUZCRFdTa1VQLS1nbWJ6bXJpeERyTkkzaHpsRjJqckNJTS1scnQybUNnY1FQeW1Oc282MXQybGZiSG1TSENZb2FvVnV2Y2l5Uk9uQThmb3FwNnVNS1JaWldIZ1ZnVWh2SmdSTUJRcEpCM1B1MlhiUkl2dF9yM2pINU9QUGg2RU52STVoVlhLU09FX3p0SzF3LVlYdFBuNklXLWcxZ0xseDlsX1ZnMkJYX2h5TkFaZmE4TXcyNVNOSWdXNTd4Tkg4WlVsdWlpZm45d1pSRjkwUV9qSC1oVDQ1azNqRXlFdUwxSjlQSzJVaXJaUE00ZtIB_gFBVV95cUxQMjRzOHFWUFpOVzhwejl5RWZkQl9mSkxESGJ2Z3FaTW5vMlNOVjI2dmJ3cEcyZFFodjZtSzM3bnh6YkNJUkZSb3hhS2lzbi1nTUVSOXItM3czQzZkQ0hvLUk2MHBNdWt6Q3lHQ2ZyOHdYVHp2TmVTSXpzdnVDWDNwYVVyc3RZb1ZHc2Q0WWxia3ZqMzFnQm9wdGNIN0RRbjFKZHc4aTNRT2MyX01lQXVncjhtR0JYOGJlbmhUd0Znai1mRnEtUXB0eG16MlgwcE9YWEZpX2Y0MlltMDM5bTBhcHlSTjhVVkllLTVYaFJ4amdrWHZLbXA3enFmdV82UQ?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-20T07:00:00+00:00", "published_display": "20 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma shares rise as arm receives an upfront payment of $700 mn", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPRVVaV0ZtVEV5S1FiMk1OT3ZYSzlLRXA3M2U0R1ljamJnYlNqaVlDdjlYX3BtV19iUHRPaDAzcFA1SHVWUXZKeDlZaWFBUGdTSm9ON0t6ekZHVWg0NllydWRjWkpQWFFjV2ItRldHTC1QS1EzdFF0Z25VeGF0SHcyVEE4ZWstWUd5a2ZHSzB4SDRzT1otWTg5OXFaRk02NHg1U3RURlhKWWhJZWZLdXk0N2NLT1RIdXBid2kwYm84VnA4ZHNxVEZadW5UZ01NZHk5d3VpUl9B0gHbAUFVX3lxTFAzbnJmcm55N0I0VjlyOV9WLXBYNTJYN2xKdlhaT1ZlSGlSZEhHRVpjdncxT2V3dmxIemd0eXdOYWpPdU5BN2ZGRm1GLVNzeEVHLWR5b3B6RkdWWkYzRmpaNjIxX05XS2otNG1RY1BPdlNZSFUtQkdBcnZZMFRoY0J4NXJrRUZhRlAyYVhGTjE1QUZ2WGpaU3puV1RmaUJMQm5ZUUw3NXJqdU5oQ202cUpZSURDUUNLcWNUMkNmYVdOZkZXN0U2aXRvM1BUZ1E5WVhybmhxWnhIZFlRWQ?oc=5", "source_name": "Business Standard", "published_at": "2025-09-09T07:00:00+00:00", "published_display": "09 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma up 3% on DCGI nod to start phase 3 trial of Envafolimab", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2025-09-05T07:00:00+00:00", "published_display": "05 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s Why Glenmark Pharma Shares Are Falling Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPaWlaQ1ZWd21mXzBGeDJYSVdxQVczaVV5TWh3emNWYm9ncnhaNmxoaVNIMFNzOWgtRFhaWllYZTNTMHJhbE9JdHZOd3BOUG1oQV9Vb0h1STI3Si01cTQxS0ZXQVpOb2RvS0FHUmlndjVCUnRQLTBDd3hvVjA0dThrYm5RUUZKYnMtSWhpWFNYWnd4eGNZQm1ab0F2ZW1lWkxuXzNwSWJRWW5ZbVcxU3IwNHUzUE93QQ?oc=5", "source_name": "Stocktwits", "published_at": "2025-08-16T07:00:00+00:00", "published_display": "16 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOUDhSa0tsMk85cjZfSjFoYnpKc01EeDN3STR6UF84ei1uSEpsRE5lRnVxckNqQ0dNNC1ZOU5LWUZFX0pmOHFTLTZuMHJCdnk0VDUzVnpBZXduR0FDZVpaRl9KeWRmeHpUNzluYWtaZnlLZzNIZlFJS19CWTVNRTMySEJfV0ZFdkJnMjZqcjBQNUliVzQ3WF9lTzNqejBEVUdaMmd6SFBpeHgzbGVhN1Q0TjVvUXkwMDRYdlp4dUZyRnVHWWI5eTJmMUFYSzNGdw?oc=5", "source_name": "Reuters", "published_at": "2025-07-11T07:00:00+00:00", "published_display": "11 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Glenmark Stock - analyst consensus and valuation snapshot", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNQTA2MkZqakJNS1QtU2F2SExRN2hZUDR4U0NFVEl5c25CMGVfZjZUSGpCd0dLYTRKWnl4R2x5OVNuNHVSUGdxX3dMbVN3Ym52eVl6VnF6X2xUdVRwamFwQ2xmeXhZWDgyVWdkRkpRRGdLMnA5LWlOU0JpanVTYzJOU1VVdHFaczkzRXBfdS03U0VOdWdNWDdMLWxDZi1WSVZiYm9PT0RzN245NXNVSE5PR21DVWc?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-21T20:38:15+00:00", "published_display": "21 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Stock - analyst consensus and outlook midyear", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPejRFWi10d01fVDR5N3hyUFBrQ002Rlh5N1VvY0dFekc5U3EyUW1HSzlOdzJXcjY5WWExUnZRZzBYcUtNNTY2NjZaMmE3OHRLRVJyMHhzOEFLeHBzN084bGRQcDQ1czVFTUJiRS1FR0VNYUlRZ29yY28zZkthQXVtS0hPZ1VOWnU5NU5salVmMmFIU3lER0pGczlRZFJ1VFFUNndfVHhNNzRvQXdxblZGcg?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-17T19:49:10+00:00", "published_display": "17 Jun 2026 19:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark launches Methylene Blue Injection in US market", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPcGJBQ0o4WHR3ZmhKTkZVZ2pKMTIxZjR3VGZya3I4b29PeEJWZWhmZ1pINzVWbWI0a0E1N0hBRm5IVl93T05rZEQyVHoxNVNLWEdfMWJFTndBNmtRZWVfdERibExZUXNQTUJOeE16VHJwYmpKQWZ4RmVsX2ZiQlpSS3BSampyWDhaajhpbGFCNmJSbmJaSGlxdHFsSWFMUWtqXzlCdzZEWEtNZHhEWVhLc2FR?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-17T04:17:23+00:00", "published_display": "17 Jun 2026 04:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharmaceuticals launches Winlevi across key European markets", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma Profit Expected To Soar 5x in Two Years, Says Motilal Oswal \u2014 Check Target Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOY09WdW11YzhKNjlPZ09LWndBb1FYS1dyNEJESTE4YmNQN3NnWUNoVWlXTUNuRUhjN19KdnhPclVNdGN5ejFRc1FCQVdxcTFQbkJlRDl4Qy16bnh4TjhVdHJpUmdKSWppRWdIYkRtNDBYNUxpeXY2ek9KWnAxTS1KVVVLSEFyRHJpazBXRk5SSE5oN2tUdnNFVlpoUXEtdkdwUHVCSmNTcGVZYzNkQVYtMkYzRjI2dDV0ZUNweHBOZzZYRjJNUkhXSGNLQkMtUlVqTHVF?oc=5", "source_name": "NDTV Profit", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Glenmark Pharmaceuticals' (NSE:GLENMARK) Healthy Earnings Might Be Conservative", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPd3NlQ0hiWkpJbE9saUxpR05ic1o5TDEtaS1XaW40WlpjWGQyRkNvSVNLWUNwMzBYakV5Y0hpM2t6QVJwSE1mQVZXalJvR3BLX3JVZlV0ZzUtLUNtZjRaVi15REdTcm5CSGlHbmV0dmlYbVJ5Q1owSFdnV3ViN19xbXNoOHIxRHFDdmhhX0ZFUzN1YkkzRG13VzZVM2dhN2g3TTJNMlMzWjVnMm02MWRfclhnZERmVzA1eXNYMEtDZjVWOFEtT2VLNkI3RVJkMkdnX09zUlc0czJTM0JZMVJaaUFBQzJEMjVMLWVOT3NJclJobGx2ell5aGNB0gH_AUFVX3lxTE9CQ09PNWIyTjFjNEJEd3ZZSjkyeERENEJRNHJ5MzZBUmx4V1VXMmF5cVI0ZG1EWDZNR0laRDM5S1RVbl9pZXE0RFF2aVN3M2E0dTk5OHNkQW10Vi1icjdtX0FIVXhuN0JnNnV6dHZfNnhOc0FKUTNQSkFROTh6aVJ5Um1NaFBQUVQtcnVKUUZNOWFtQkoxSzlKM2dJX3l0TWFHZFI1SUJJTTNXcDdnLW1mbnRVUEtMbUZGbzBzSGFZUzNHR2huTXJWa21vOG1RRUliMHlIczNzZWZ2ZGtjcDRmWWdESTZZVU5mcURheWF2TEhwRjV2WHFNOS1rM3pUOA?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Launches Lacosamide Injection; Shares Rise 1%", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNVUJ1cUVwTkMzUU5lM0RSdXVvWXBWTGRWWGVGaTY2dm9PejRvRERUbk9CbjRqRnlBWTlxS051ZzNhSGppdDdiR2ZFUlhkYUEzWkU3OGp3aUpyT3E1UkNMT2RMX2x1WV9QRTZuc0JBX1pSTDdXSV82UXJoM2ctTndHNFFFQUplM2JSYlNidW9keFBFRDFZOUx3?oc=5", "source_name": "HDFC Sky", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Now The Time To Put Glenmark Pharmaceuticals (NSE:GLENMARK) On Your Watchlist?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks to Watch for June 1: IndiGo, Glenmark Pharma, Lupin, NMDC, textile stocks and more", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma Q4 Result: Net Profit Soars 64 Times, Revenue Rises; Dividend Declared", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "NDTV Profit", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma Q4 net profit zooms to \u20b9301 crore; recommends 250% dividend", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark to host Annual Investor Day 2026 on June 9", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQSjcyNlBtc2d5UmMzWHFjM3ZheHdJa1oxclhPQ29hd29rdmZiZTJINFVKcU1OZlAxVkVNRmUzU1Q3U3JTNGtxR0piaGZoQXhaLURmNmxMZ1dOZkY1QkJHLWxXT2N6V2NyYVhzeGxLblZ0ZGtUVjA0S3FQR1BxVDc3N2R2QnB5UUJXWHBRRDBEX01ISUdkTGZuYml0VGZwRzZCSEVWMTZna2JOYURy?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharmaceuticals stock (INE935A01035): shares under pressure on NSE India as investors track", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOamdUS05XTzlFcWUzQmVlWDZWMWwwODJLR1F1UnhyTEJjWWRvY0FfeWRXdnl1Yi1fRTlFTkxhcHVLbTNNcXdZbC1QLWtLZEowM3lLdmxtS0hRMkt3d2NsOXNjcGpnZ2s3RnRYNHdlMnNiTXRIaThZYWhadEpsRzA1alZLMjNURXBWTERfU0N0dFk5RHpSTDRyUmVaOHpYblNRTi1KRXMtVFA2cnUwVmFvbW9XMkhEc29CaHRNMXBpOFVGMFRNamc?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks to Watch Today: TVS Motor, Exide Industries, Meesho, Groww, Gujarat Themis, Glenmark Pharma,...", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Launches Vancomycin Injection; Shares Dip 0.36%", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPMk1abzhNRFIwNXg1Q1FFb296a2Jmbm5vSGsxWVBlVTZIelM0YkVBZW5xY1RpVU5ELXgxTmlqd1lZTi0yN3pkUWw3ZFhWSU1zYTlLS1F6SG04NlAxUFJtODF3bzl1VEJPS0VSaTlHMjBTRndKVnVOR0tEQjlJelhULTJwQ2VLZmM0VXFDTVJmZ1F1V0pUdkFYeVdR?oc=5", "source_name": "HDFC Sky", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharmaceuticals Ltd slips for fifth straight session", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nifty eyes 24,600; SBI, Glenmark Pharma, Tata Power on analyst radar", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma may outperform amid market correction; technicals turn positive: Ruchit Jain", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trade Spotlight: How should you trade Avenue Supermarts, Glenmark, Bharat Dynamics, Torrent Pharma,...", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma Q3: Profit, revenue up over 15% as India, North America drive growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Q3 profit rises 16% on strong India, US performance", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Q3 profit rises 15% on strong market performance; Revenue up 15%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma stock gains 3% on launch novel COPD treatment; details here", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2025-11-25T08:00:00+00:00", "published_display": "25 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharmaceuticals Limited Just Beat Revenue By 16%: Here's What Analysts Think Will Happen Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPamVkem9vaTRQemUyNmIxOVEySHVLVEZmazhLMWVkRFdCbjF0VllOd0ZNcEVGTmQ0YzBZNHR5c0drTktmbVFjYlY2RnQySEZlcU1OVEJHTGtZdG5HME1rWHdzTlo2alRPQTRVekE5TUZHWGhsYlRxejUwZV9vd0lBTFVDVTN2LWVieFBmaWF1NmhGYmVDSHgxMTFJYndpU3FXelRHUDdwbnNWd1BIVjFaQnd0NWhHTTNCWTZBeTlfZ3JGak9iWkl0ejVUUjdEWWVTbHhDOXdpVWdZRElmXzVzRVd4TkViRTFHMC1fQm5jVXh0TEM1SmxSVWZB0gH_AUFVX3lxTFA3cG1pSVVOU3gzNnlkRTdTRHdCaG1nM2tGaDV2MVhRaVg1WkNjZml1ZGV4aFc5THdBQ1daU2pvdm9ZMjhPbFhzalg4UGtHT244NWJuS0NQX1lIbEx6ajlhU1hqemtaeldkUXBVLUxrOXhHRjlMMnFNWGdJblRUY1B3U2ZxS0ZVRWljNENqMm14bUlBWjBKUmJyY1E3clllUFpiRlZ6dkdGQmliUGhXclR0a08xMVV3NFk1ZlZKMHVZb0lKTW5HNmtrWmJCQlRkRTZsOTg5OHJIaktZcGRZa1FEMUVZNjlISXdkYVVoNHFzNmtmZklubkxRV3laTjJHSQ?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-19T08:00:00+00:00", "published_display": "19 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Getting In Cheap On Glenmark Pharmaceuticals Limited (NSE:GLENMARK) Might Be Difficult", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPQjVHbEFwa19pYmJhaHhlLVpjUmRUczFrWkNqdnlXX01ucEx2LUp3TUIzcGRpQWpuV1dabjhKV0V3Wl83ZHc0V0p0el9IdDUtTmtfUExDRWFmTFJYbm9QWlowakxpWnhuamVxbThWUVl0andMU0pzV0xHVWs4dUxaSV9JdkczX2kySHJPcXI2V08xQXFvOWRWU2h3VHBKeXBFbjNwRlBsRWQxOS1ncjVPcDdYTlNiUkhLdklWZDFyYlpSZlB4ZlpjUlptaG84azFjTHdHd1JpSjdqejdWWVR4ZkxXV21lTUdYX1pCeko0WHYzczQ2ZmZsTzZn0gH_AUFVX3lxTE45UU1RQjVGVmF1N0gxbllURDNyWlNLR2pUb2RySGFSMjEwaHBOdGswcmFQd0dXSTdMSVR5Q2xackVzVzNNMnZPZ0RKYTlla3JneHlQc3Y0aDZRYVNkVVhSUEEyS25IQ0sxYkdSdzZGOHA4Wjl1aldTU0xpa1dhVk5UTVkwdXFoREJkSEdUYWRmWnByU0Q5SlJQcFpQMnVrTHB0ZnRUeURSUlpmRTFhcVlFWEEyeG15MU5FQWlfbk4tckFiREF1Tm94NGVGQzF6Z1dSUGFXM1daQVI3eDlkelNXS3pZNjlLbVY1RVZlOGd2bVY3bmVjOXpDZFRLaTdZVQ?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-12T08:00:00+00:00", "published_display": "12 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why Glenmark Pharmaceuticals Limited's (NSE:GLENMARK) CEO Compensation Is The Least Of Shareholders' Concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxNQjFKQUZCRFdTa1VQLS1nbWJ6bXJpeERyTkkzaHpsRjJqckNJTS1scnQybUNnY1FQeW1Oc282MXQybGZiSG1TSENZb2FvVnV2Y2l5Uk9uQThmb3FwNnVNS1JaWldIZ1ZnVWh2SmdSTUJRcEpCM1B1MlhiUkl2dF9yM2pINU9QUGg2RU52STVoVlhLU09FX3p0SzF3LVlYdFBuNklXLWcxZ0xseDlsX1ZnMkJYX2h5TkFaZmE4TXcyNVNOSWdXNTd4Tkg4WlVsdWlpZm45d1pSRjkwUV9qSC1oVDQ1azNqRXlFdUwxSjlQSzJVaXJaUE00ZtIB_gFBVV95cUxQMjRzOHFWUFpOVzhwejl5RWZkQl9mSkxESGJ2Z3FaTW5vMlNOVjI2dmJ3cEcyZFFodjZtSzM3bnh6YkNJUkZSb3hhS2lzbi1nTUVSOXItM3czQzZkQ0hvLUk2MHBNdWt6Q3lHQ2ZyOHdYVHp2TmVTSXpzdnVDWDNwYVVyc3RZb1ZHc2Q0WWxia3ZqMzFnQm9wdGNIN0RRbjFKZHc4aTNRT2MyX01lQXVncjhtR0JYOGJlbmhUd0Znai1mRnEtUXB0eG16MlgwcE9YWEZpX2Y0MlltMDM5bTBhcHlSTjhVVkllLTVYaFJ4amdrWHZLbXA3enFmdV82UQ?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-20T07:00:00+00:00", "published_display": "20 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma shares rise as arm receives an upfront payment of $700 mn", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPRVVaV0ZtVEV5S1FiMk1OT3ZYSzlLRXA3M2U0R1ljamJnYlNqaVlDdjlYX3BtV19iUHRPaDAzcFA1SHVWUXZKeDlZaWFBUGdTSm9ON0t6ekZHVWg0NllydWRjWkpQWFFjV2ItRldHTC1QS1EzdFF0Z25VeGF0SHcyVEE4ZWstWUd5a2ZHSzB4SDRzT1otWTg5OXFaRk02NHg1U3RURlhKWWhJZWZLdXk0N2NLT1RIdXBid2kwYm84VnA4ZHNxVEZadW5UZ01NZHk5d3VpUl9B0gHbAUFVX3lxTFAzbnJmcm55N0I0VjlyOV9WLXBYNTJYN2xKdlhaT1ZlSGlSZEhHRVpjdncxT2V3dmxIemd0eXdOYWpPdU5BN2ZGRm1GLVNzeEVHLWR5b3B6RkdWWkYzRmpaNjIxX05XS2otNG1RY1BPdlNZSFUtQkdBcnZZMFRoY0J4NXJrRUZhRlAyYVhGTjE1QUZ2WGpaU3puV1RmaUJMQm5ZUUw3NXJqdU5oQ202cUpZSURDUUNLcWNUMkNmYVdOZkZXN0U2aXRvM1BUZ1E5WVhybmhxWnhIZFlRWQ?oc=5", "source_name": "Business Standard", "published_at": "2025-09-09T07:00:00+00:00", "published_display": "09 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Glenmark Pharma up 3% on DCGI nod to start phase 3 trial of Envafolimab", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2025-09-05T07:00:00+00:00", "published_display": "05 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s Why Glenmark Pharma Shares Are Falling Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPaWlaQ1ZWd21mXzBGeDJYSVdxQVczaVV5TWh3emNWYm9ncnhaNmxoaVNIMFNzOWgtRFhaWllYZTNTMHJhbE9JdHZOd3BOUG1oQV9Vb0h1STI3Si01cTQxS0ZXQVpOb2RvS0FHUmlndjVCUnRQLTBDd3hvVjA0dThrYm5RUUZKYnMtSWhpWFNYWnd4eGNZQm1ab0F2ZW1lWkxuXzNwSWJRWW5ZbVcxU3IwNHUzUE93QQ?oc=5", "source_name": "Stocktwits", "published_at": "2025-08-16T07:00:00+00:00", "published_display": "16 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOUDhSa0tsMk85cjZfSjFoYnpKc01EeDN3STR6UF84ei1uSEpsRE5lRnVxckNqQ0dNNC1ZOU5LWUZFX0pmOHFTLTZuMHJCdnk0VDUzVnpBZXduR0FDZVpaRl9KeWRmeHpUNzluYWtaZnlLZzNIZlFJS19CWTVNRTMySEJfV0ZFdkJnMjZqcjBQNUliVzQ3WF9lTzNqejBEVUdaMmd6SFBpeHgzbGVhN1Q0TjVvUXkwMDRYdlp4dUZyRnVHWWI5eTJmMUFYSzNGdw?oc=5", "source_name": "Reuters", "published_at": "2025-07-11T07:00:00+00:00", "published_display": "11 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 59, "total_relevant": 32, "sentiment_summary": {"positive": 11, "negative": 0, "neutral": 21, "score": 59, "total": 32, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 12.15, "count": 17}, {"event": "earnings", "label": "Earnings", "weight": 6.5, "count": 8}, {"event": "analyst", "label": "Analyst action", "weight": 3.25, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 0.9, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 11, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2213.6, "latest_week": "2026-06-19", "one_week_move": 1.8, "four_week_move": -2.0, "twelve_week_move": 2.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.361726, "market_dynamics_buy_signal": false, "relative_strength": 10.984191, "fair_value_gap": 49.2, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 60.2157, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.8% over one week, -2.0% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 68, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Business Standard", "count": 7}, {"label": "simplywall.st", "count": 5}, {"label": "AD HOC NEWS", "count": 4}, {"label": "Moneycontrol.com", "count": 3}, {"label": "CNBC TV18", "count": 3}, {"label": "scanx.trade", "count": 2}, {"label": "NDTV Profit", "count": 2}, {"label": "HDFC Sky", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 32}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 17}, {"label": "Earnings", "count": 8}, {"label": "Analyst action", "count": 4}, {"label": "Guidance", "count": 1}, {"label": "Capital return", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "59/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "32", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "18", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+1.8% over one week, -2.0% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Glenmark Stock - analyst consensus and valuation snapshot"}], "updated_at": "2026-06-22T18:08:02.680885+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}